This talk was presented at the 2018 SAGES Meeting/16th World Congress of Endoscopic Surgery by David Cummings during the Masters Bariatrics: Revision and Reversal on April 11 2018
Keyword(s): adults, ARMMS-T2D trial, banded gastric bypass, banded laparoscopic sleeve gastrectomy, blood loss, blood pressure, BLSG, BMI, body mass index, conversion, conversional surgery, COSMID trial, Covidien, diabetes, diabetes remission, endoscopy, EWL, excess weight loss, fasting plasma glucose, gastric bypass, GERD, glycemia, glycemic control, HbA1c, hematocrit, hemoglobin A1c, hemorrhage, intention-to-treat, Johnson & Johnson, Lap band, laparoscopic sleeve gastrectomy, lipids, LSG, metabolic surgery, metric, N&V, National Institutes of Health, nausea & vomiting, NIH, obese, one anastomosis duodeno-ileal bypass, operative time, PI, principle investigator, prospective, remnant sleeve, reversal, revisional bariatric surgery, risks, SADI, safety, satiety, stomach, tolerability survey, transfusion, weight loss, weight regain
Banded vs non-banded sleeve gastrectomy study–5:19
Contributors–18:27